注射用組換え凝固Ⅷ因子のグローバル市場インサイト・予測（～2027年）

• 英文タイトル：Global Recombinant Coagulation Factor Ⅷ for Injection Market Insights and Forecast to 2027

• レポートコード：QY2112C03921 • 出版社/出版日：QYResearch / 2021年12月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、114ページ • 納品方法：Eメール（納期：3日） • 産業分類：医薬品

• 販売価格（消費税別）

Single User	￥735,000 (USD4,900)	▷ お問い合わせ
Multi User	￥1,102,500 (USD7,350)	▷ お問い合わせ
Enterprise License	￥1,470,000 (USD9,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

本調査資料は注射用組換え凝固Ⅷ因子の世界市場の現状について調査・分析し、2027年までの市場を予測しました。注射用組換え凝固Ⅷ因子の世界市場概要、メーカー別の競争状況と市場シェア、種類別市場規模（250 IU/ボトル、500 IU/ボトル、1000 IU/ボトル、2000 IU/ボトル）、用途別市場規模（病院、クリニック、その他）、主要地域別市場規模（北米・アメリカ、ヨーロッパ、アジア・日本・中国・インド、中南米、中東・アフリカ）、関連企業の情報、バリューチェーン・販売チャネル、市場動向などを収録しています。 ・注射用組換え凝固Ⅷ因子の世界市場概要 ・メーカー別の競争状況、市場シェア ・注射用組換え凝固Ⅷ因子の種類別市場規模：250 IU/ボトル、500 IU/ボトル、1000 IU/ボトル、2000 IU/ボトル ・注射用組換え凝固Ⅷ因子の用途別市場規模：病院、クリニック、その他 ・北米の注射用組換え凝固Ⅷ因子市場規模2016-2027：種類別、用途別、国別（アメリカ、カナダ） ・ヨーロッパの注射用組換え凝固Ⅷ因子市場規模2016-2027：種類別、用途別、国別（ドイツ、フランス、イギリス） ・アジアの注射用組換え凝固Ⅷ因子市場規模2016-2027：種類別、用途別、国別（日本、中国、インド、韓国） ・中南米の注射用組換え凝固Ⅷ因子市場規模2016-2027：種類別、用途別、国別（メキシコ、ブラジル） ・中東・アフリカの注射用組換え凝固Ⅷ因子市場規模2016-2027：種類別、用途別、国別（トルコ、サウジアラビア） ・企業情報：Pfizer、Novo Nordisk A/S、Baxter、Bayer、GC Pharma、Shanghai Raas Corp、Hualan Biological、Shandong Taibang Biological Products、Shanghai Xinxing Medicine、SinoCell Tech ・注射用組換え凝固Ⅷ因子のバリューチェーン・販売チャネル分析 ・注射用組換え凝固Ⅷ因子の世界市場動向

Recombinant Coagulation Factor VIII for Injection, This product is used in the treatment of haemophilia A with plasma coagulation factor VIII (F VIII) deficiency. It acts as a temporary substitute for the missing clotting factor in the correction or prevention of bleeding, emergency or elective surgery.

Market Analysis and Insights: Global Recombinant Coagulation Factor Ⅷ for Injection Market
The global Recombinant Coagulation Factor Ⅷ for Injection market is valued at US$ million in 2020. The market size will reach US$ million by the end of 2027, growing at a CAGR of % during 2021-2027.

Global Recombinant Coagulation Factor Ⅷ for Injection Scope and Segment
Recombinant Coagulation Factor Ⅷ for Injection market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Recombinant Coagulation Factor Ⅷ for Injection market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2016-2027.

Segment by Type
250 IU/Bottle
500 IU/Bottle
1000 IU/Bottle
2000 IU/Bottle

Segment by Application
Hospital
Clinic
Others

By Company
Pfizer
Novo Nordisk A/S
Baxter
Bayer
GC Pharma
Shanghai Raas Corp
Hualan Biological
Shandong Taibang Biological Products
Shanghai Xinxing Medicine
SinoCell Tech

By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE

レポート目次

---

1 Study Coverage
1.1 Recombinant Coagulation Factor Ⅷ for Injection Product Introduction
1.2 Market by Type
1.2.1 Global Recombinant Coagulation Factor Ⅷ for Injection Market Size Growth Rate by Type
1.2.2 250 IU/Bottle
1.2.3 500 IU/Bottle
1.2.4 1000 IU/Bottle
1.2.5 2000 IU/Bottle
1.3 Market by Application
1.3.1 Global Recombinant Coagulation Factor Ⅷ for Injection Market Size Growth Rate by Application
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered

2 Executive Summary
2.1 Global Recombinant Coagulation Factor Ⅷ for Injection Sales Estimates and Forecasts 2016-2027
2.2 Global Recombinant Coagulation Factor Ⅷ for Injection Revenue Estimates and Forecasts 2016-2027
2.3 Global Recombinant Coagulation Factor Ⅷ for Injection Revenue by Region: 2016 VS 2021 VS 2027
2.4 Global Top Recombinant Coagulation Factor Ⅷ for Injection Regions by Sales
2.4.1 Global Top Recombinant Coagulation Factor Ⅷ for Injection Regions by Sales (2016-2021)
2.4.2 Global Top Recombinant Coagulation Factor Ⅷ for Injection Regions by Sales (2022-2027)
2.5 Global Top Recombinant Coagulation Factor Ⅷ for Injection Regions by Revenue
2.5.1 Global Top Recombinant Coagulation Factor Ⅷ for Injection Regions by Revenue (2016-2021)
2.5.2 Global Top Recombinant Coagulation Factor Ⅷ for Injection Regions by Revenue (2022-2027)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa

3 Competition by Manufacturers
3.1 Global Recombinant Coagulation Factor Ⅷ for Injection Sales by Manufacturers
3.1.1 Global Top Recombinant Coagulation Factor Ⅷ for Injection Manufacturers by Sales (2016-2021)
3.1.2 Global Top Recombinant Coagulation Factor Ⅷ for Injection Manufacturers Market Share by Sales (2016-2021)
3.1.3 Global Top 10 and Top 5 Companies by Recombinant Coagulation Factor Ⅷ for Injection Sales in 2020
3.2 Global Recombinant Coagulation Factor Ⅷ for Injection Revenue by Manufacturers
3.2.1 Global Top Recombinant Coagulation Factor Ⅷ for Injection Manufacturers by Revenue (2016-2021)
3.2.2 Global Top Recombinant Coagulation Factor Ⅷ for Injection Manufacturers Market Share by Revenue (2016-2021)
3.2.3 Global Top 10 and Top 5 Companies by Recombinant Coagulation Factor Ⅷ for Injection Revenue in 2020
3.3 Global Recombinant Coagulation Factor Ⅷ for Injection Sales Price by Manufacturers
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Recombinant Coagulation Factor Ⅷ for Injection Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Recombinant Coagulation Factor Ⅷ for Injection Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type
4.1 Global Recombinant Coagulation Factor Ⅷ for Injection Sales by Type
4.1.1 Global Recombinant Coagulation Factor Ⅷ for Injection Historical Sales by Type (2016-2021)
4.1.2 Global Recombinant Coagulation Factor Ⅷ for Injection Forecasted Sales by Type (2022-2027)
4.1.3 Global Recombinant Coagulation Factor Ⅷ for Injection Sales Market Share by Type (2016-2027)
4.2 Global Recombinant Coagulation Factor Ⅷ for Injection Revenue by Type
4.2.1 Global Recombinant Coagulation Factor Ⅷ for Injection Historical Revenue by Type (2016-2021)
4.2.2 Global Recombinant Coagulation Factor Ⅷ for Injection Forecasted Revenue by Type (2022-2027)
4.2.3 Global Recombinant Coagulation Factor Ⅷ for Injection Revenue Market Share by Type (2016-2027)
4.3 Global Recombinant Coagulation Factor Ⅷ for Injection Price by Type
4.3.1 Global Recombinant Coagulation Factor Ⅷ for Injection Price by Type (2016-2021)
4.3.2 Global Recombinant Coagulation Factor Ⅷ for Injection Price Forecast by Type (2022-2027)

5 Market Size by Application
5.1 Global Recombinant Coagulation Factor Ⅷ for Injection Sales by Application
5.1.1 Global Recombinant Coagulation Factor Ⅷ for Injection Historical Sales by Application (2016-2021)
5.1.2 Global Recombinant Coagulation Factor Ⅷ for Injection Forecasted Sales by Application (2022-2027)
5.1.3 Global Recombinant Coagulation Factor Ⅷ for Injection Sales Market Share by Application (2016-2027)
5.2 Global Recombinant Coagulation Factor Ⅷ for Injection Revenue by Application
5.2.1 Global Recombinant Coagulation Factor Ⅷ for Injection Historical Revenue by Application (2016-2021)
5.2.2 Global Recombinant Coagulation Factor Ⅷ for Injection Forecasted Revenue by Application (2022-2027)
5.2.3 Global Recombinant Coagulation Factor Ⅷ for Injection Revenue Market Share by Application (2016-2027)
5.3 Global Recombinant Coagulation Factor Ⅷ for Injection Price by Application
5.3.1 Global Recombinant Coagulation Factor Ⅷ for Injection Price by Application (2016-2021)
5.3.2 Global Recombinant Coagulation Factor Ⅷ for Injection Price Forecast by Application (2022-2027)

6 North America
6.1 North America Recombinant Coagulation Factor Ⅷ for Injection Market Size by Type
6.1.1 North America Recombinant Coagulation Factor Ⅷ for Injection Sales by Type (2016-2027)
6.1.2 North America Recombinant Coagulation Factor Ⅷ for Injection Revenue by Type (2016-2027)
6.2 North America Recombinant Coagulation Factor Ⅷ for Injection Market Size by Application
6.2.1 North America Recombinant Coagulation Factor Ⅷ for Injection Sales by Application (2016-2027)
6.2.2 North America Recombinant Coagulation Factor Ⅷ for Injection Revenue by Application (2016-2027)
6.3 North America Recombinant Coagulation Factor Ⅷ for Injection Market Size by Country
6.3.1 North America Recombinant Coagulation Factor Ⅷ for Injection Sales by Country (2016-2027)
6.3.2 North America Recombinant Coagulation Factor Ⅷ for Injection Revenue by Country (2016-2027)
6.3.3 United States
6.3.4 Canada

7 Europe
7.1 Europe Recombinant Coagulation Factor Ⅷ for Injection Market Size by Type
7.1.1 Europe Recombinant Coagulation Factor Ⅷ for Injection Sales by Type (2016-2027)
7.1.2 Europe Recombinant Coagulation Factor Ⅷ for Injection Revenue by Type (2016-2027)
7.2 Europe Recombinant Coagulation Factor Ⅷ for Injection Market Size by Application
7.2.1 Europe Recombinant Coagulation Factor Ⅷ for Injection Sales by Application (2016-2027)
7.2.2 Europe Recombinant Coagulation Factor Ⅷ for Injection Revenue by Application (2016-2027)
7.3 Europe Recombinant Coagulation Factor Ⅷ for Injection Market Size by Country
7.3.1 Europe Recombinant Coagulation Factor Ⅷ for Injection Sales by Country (2016-2027)
7.3.2 Europe Recombinant Coagulation Factor Ⅷ for Injection Revenue by Country (2016-2027)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia

8 Asia Pacific
8.1 Asia Pacific Recombinant Coagulation Factor Ⅷ for Injection Market Size by Type
8.1.1 Asia Pacific Recombinant Coagulation Factor Ⅷ for Injection Sales by Type (2016-2027)
8.1.2 Asia Pacific Recombinant Coagulation Factor Ⅷ for Injection Revenue by Type (2016-2027)
8.2 Asia Pacific Recombinant Coagulation Factor Ⅷ for Injection Market Size by Application
8.2.1 Asia Pacific Recombinant Coagulation Factor Ⅷ for Injection Sales by Application (2016-2027)
8.2.2 Asia Pacific Recombinant Coagulation Factor Ⅷ for Injection Revenue by Application (2016-2027)
8.3 Asia Pacific Recombinant Coagulation Factor Ⅷ for Injection Market Size by Region
8.3.1 Asia Pacific Recombinant Coagulation Factor Ⅷ for Injection Sales by Region (2016-2027)
8.3.2 Asia Pacific Recombinant Coagulation Factor Ⅷ for Injection Revenue by Region (2016-2027)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 China Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia

9 Latin America
9.1 Latin America Recombinant Coagulation Factor Ⅷ for Injection Market Size by Type
9.1.1 Latin America Recombinant Coagulation Factor Ⅷ for Injection Sales by Type (2016-2027)
9.1.2 Latin America Recombinant Coagulation Factor Ⅷ for Injection Revenue by Type (2016-2027)
9.2 Latin America Recombinant Coagulation Factor Ⅷ for Injection Market Size by Application
9.2.1 Latin America Recombinant Coagulation Factor Ⅷ for Injection Sales by Application (2016-2027)
9.2.2 Latin America Recombinant Coagulation Factor Ⅷ for Injection Revenue by Application (2016-2027)
9.3 Latin America Recombinant Coagulation Factor Ⅷ for Injection Market Size by Country
9.3.1 Latin America Recombinant Coagulation Factor Ⅷ for Injection Sales by Country (2016-2027)
9.3.2 Latin America Recombinant Coagulation Factor Ⅷ for Injection Revenue by Country (2016-2027)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
9.3.6 Colombia

10 Middle East and Africa
10.1 Middle East and Africa Recombinant Coagulation Factor Ⅷ for Injection Market Size by Type
10.1.1 Middle East and Africa Recombinant Coagulation Factor Ⅷ for Injection Sales by Type (2016-2027)
10.1.2 Middle East and Africa Recombinant Coagulation Factor Ⅷ for Injection Revenue by Type (2016-2027)
10.2 Middle East and Africa Recombinant Coagulation Factor Ⅷ for Injection Market Size by Application
10.2.1 Middle East and Africa Recombinant Coagulation Factor Ⅷ for Injection Sales by Application (2016-2027)
10.2.2 Middle East and Africa Recombinant Coagulation Factor Ⅷ for Injection Revenue by Application (2016-2027)
10.3 Middle East and Africa Recombinant Coagulation Factor Ⅷ for Injection Market Size by Country
10.3.1 Middle East and Africa Recombinant Coagulation Factor Ⅷ for Injection Sales by Country (2016-2027)
10.3.2 Middle East and Africa Recombinant Coagulation Factor Ⅷ for Injection Revenue by Country (2016-2027)
10.3.3 Turkey
10.3.4 Saudi Arabia

11 Company Profiles
11.1 Pfizer
11.1.1 Pfizer Corporation Information
11.1.2 Pfizer Overview
11.1.3 Pfizer Recombinant Coagulation Factor Ⅷ for Injection Sales, Price, Revenue and Gross Margin (2016-2021)
11.1.4 Pfizer Recombinant Coagulation Factor Ⅷ for Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Pfizer Recent Developments
11.2 Novo Nordisk A/S
11.2.1 Novo Nordisk A/S Corporation Information
11.2.2 Novo Nordisk A/S Overview
11.2.3 Novo Nordisk A/S Recombinant Coagulation Factor Ⅷ for Injection Sales, Price, Revenue and Gross Margin (2016-2021)
11.2.4 Novo Nordisk A/S Recombinant Coagulation Factor Ⅷ for Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Novo Nordisk A/S Recent Developments
11.3 Baxter
11.3.1 Baxter Corporation Information
11.3.2 Baxter Overview
11.3.3 Baxter Recombinant Coagulation Factor Ⅷ for Injection Sales, Price, Revenue and Gross Margin (2016-2021)
11.3.4 Baxter Recombinant Coagulation Factor Ⅷ for Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Baxter Recent Developments
11.4 Bayer
11.4.1 Bayer Corporation Information
11.4.2 Bayer Overview
11.4.3 Bayer Recombinant Coagulation Factor Ⅷ for Injection Sales, Price, Revenue and Gross Margin (2016-2021)
11.4.4 Bayer Recombinant Coagulation Factor Ⅷ for Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Bayer Recent Developments
11.5 GC Pharma
11.5.1 GC Pharma Corporation Information
11.5.2 GC Pharma Overview
11.5.3 GC Pharma Recombinant Coagulation Factor Ⅷ for Injection Sales, Price, Revenue and Gross Margin (2016-2021)
11.5.4 GC Pharma Recombinant Coagulation Factor Ⅷ for Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 GC Pharma Recent Developments
11.6 Shanghai Raas Corp
11.6.1 Shanghai Raas Corp Corporation Information
11.6.2 Shanghai Raas Corp Overview
11.6.3 Shanghai Raas Corp Recombinant Coagulation Factor Ⅷ for Injection Sales, Price, Revenue and Gross Margin (2016-2021)
11.6.4 Shanghai Raas Corp Recombinant Coagulation Factor Ⅷ for Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Shanghai Raas Corp Recent Developments
11.7 Hualan Biological
11.7.1 Hualan Biological Corporation Information
11.7.2 Hualan Biological Overview
11.7.3 Hualan Biological Recombinant Coagulation Factor Ⅷ for Injection Sales, Price, Revenue and Gross Margin (2016-2021)
11.7.4 Hualan Biological Recombinant Coagulation Factor Ⅷ for Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Hualan Biological Recent Developments
11.8 Shandong Taibang Biological Products
11.8.1 Shandong Taibang Biological Products Corporation Information
11.8.2 Shandong Taibang Biological Products Overview
11.8.3 Shandong Taibang Biological Products Recombinant Coagulation Factor Ⅷ for Injection Sales, Price, Revenue and Gross Margin (2016-2021)
11.8.4 Shandong Taibang Biological Products Recombinant Coagulation Factor Ⅷ for Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Shandong Taibang Biological Products Recent Developments
11.9 Shanghai Xinxing Medicine
11.9.1 Shanghai Xinxing Medicine Corporation Information
11.9.2 Shanghai Xinxing Medicine Overview
11.9.3 Shanghai Xinxing Medicine Recombinant Coagulation Factor Ⅷ for Injection Sales, Price, Revenue and Gross Margin (2016-2021)
11.9.4 Shanghai Xinxing Medicine Recombinant Coagulation Factor Ⅷ for Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Shanghai Xinxing Medicine Recent Developments
11.10 SinoCell Tech
11.10.1 SinoCell Tech Corporation Information
11.10.2 SinoCell Tech Overview
11.10.3 SinoCell Tech Recombinant Coagulation Factor Ⅷ for Injection Sales, Price, Revenue and Gross Margin (2016-2021)
11.10.4 SinoCell Tech Recombinant Coagulation Factor Ⅷ for Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 SinoCell Tech Recent Developments

12 Value Chain and Sales Channels Analysis
12.1 Recombinant Coagulation Factor Ⅷ for Injection Value Chain Analysis
12.2 Recombinant Coagulation Factor Ⅷ for Injection Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Recombinant Coagulation Factor Ⅷ for Injection Production Mode & Process
12.4 Recombinant Coagulation Factor Ⅷ for Injection Sales and Marketing
12.4.1 Recombinant Coagulation Factor Ⅷ for Injection Sales Channels
12.4.2 Recombinant Coagulation Factor Ⅷ for Injection Distributors
12.5 Recombinant Coagulation Factor Ⅷ for Injection Customers

13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Recombinant Coagulation Factor Ⅷ for Injection Industry Trends
13.2 Recombinant Coagulation Factor Ⅷ for Injection Market Drivers
13.3 Recombinant Coagulation Factor Ⅷ for Injection Market Challenges
13.4 Recombinant Coagulation Factor Ⅷ for Injection Market Restraints

14 Key Findings in The Global Recombinant Coagulation Factor Ⅷ for Injection Study

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Tables
Table 1. Global Recombinant Coagulation Factor Ⅷ for Injection Market Size Growth Rate by Type, 2016 VS 2021 VS 2027 (US$ Million)
Table 2. Major Manufacturers of 250 IU/Bottle
Table 3. Major Manufacturers of 500 IU/Bottle
Table 4. Major Manufacturers of 1000 IU/Bottle
Table 5. Major Manufacturers of 2000 IU/Bottle
Table 6. Global Recombinant Coagulation Factor Ⅷ for Injection Market Size Growth Rate by Application, 2016 VS 2021 VS 2027 (US$ Million)
Table 7. Global Recombinant Coagulation Factor Ⅷ for Injection Revenue by Region: 2016 VS 2021 VS 2027 (US$ Million)
Table 8. Global Recombinant Coagulation Factor Ⅷ for Injection Sales by Region (2016-2021) & (K Bottle)
Table 9. Global Recombinant Coagulation Factor Ⅷ for Injection Sales Market Share by Region (2016-2021)
Table 10. Global Recombinant Coagulation Factor Ⅷ for Injection Sales by Region (2022-2027) & (K Bottle)
Table 11. Global Recombinant Coagulation Factor Ⅷ for Injection Sales Market Share by Region (2022-2027)
Table 12. Global Recombinant Coagulation Factor Ⅷ for Injection Revenue by Region (2016-2021) & (US$ Million)
Table 13. Global Recombinant Coagulation Factor Ⅷ for Injection Revenue Market Share by Region (2016-2021)
Table 14. Global Recombinant Coagulation Factor Ⅷ for Injection Revenue by Region (2022-2027) & (US$ Million)
Table 15. Global Recombinant Coagulation Factor Ⅷ for Injection Revenue Market Share by Region (2022-2027)
Table 16. Global Recombinant Coagulation Factor Ⅷ for Injection Sales by Manufacturers (2016-2021) & (K Bottle)
Table 17. Global Recombinant Coagulation Factor Ⅷ for Injection Sales Share by Manufacturers (2016-2021)
Table 18. Global Recombinant Coagulation Factor Ⅷ for Injection Revenue by Manufacturers (2016-2021) & (US$ Million)
Table 19. Global Recombinant Coagulation Factor Ⅷ for Injection Revenue Share by Manufacturers (2016-2021)
Table 20. Recombinant Coagulation Factor Ⅷ for Injection Price by Manufacturers 2016-2021 (US$/Bottle)
Table 21. Global Recombinant Coagulation Factor Ⅷ for Injection Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 22. Global Recombinant Coagulation Factor Ⅷ for Injection by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Recombinant Coagulation Factor Ⅷ for Injection as of 2020)
Table 23. Recombinant Coagulation Factor Ⅷ for Injection Manufacturing Base Distribution and Headquarters
Table 24. Manufacturers Recombinant Coagulation Factor Ⅷ for Injection Product Offered
Table 25. Date of Manufacturers Enter into Recombinant Coagulation Factor Ⅷ for Injection Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Recombinant Coagulation Factor Ⅷ for Injection Sales by Type (2016-2021) & (K Bottle)
Table 28. Global Recombinant Coagulation Factor Ⅷ for Injection Sales by Type (2022-2027) & (K Bottle)
Table 29. Global Recombinant Coagulation Factor Ⅷ for Injection Sales Share by Type (2016-2021)
Table 30. Global Recombinant Coagulation Factor Ⅷ for Injection Sales Share by Type (2022-2027)
Table 31. Global Recombinant Coagulation Factor Ⅷ for Injection Revenue by Type (2016-2021) & (US$ Million)
Table 32. Global Recombinant Coagulation Factor Ⅷ for Injection Revenue by Type (2022-2027) & (US$ Million)
Table 33. Global Recombinant Coagulation Factor Ⅷ for Injection Revenue Share by Type (2016-2021)
Table 34. Global Recombinant Coagulation Factor Ⅷ for Injection Revenue Share by Type (2022-2027)
Table 35. Recombinant Coagulation Factor Ⅷ for Injection Price by Type (2016-2021) & (US$/Bottle)
Table 36. Global Recombinant Coagulation Factor Ⅷ for Injection Price Forecast by Type (2022-2027) & (US$/Bottle)
Table 37. Global Recombinant Coagulation Factor Ⅷ for Injection Sales by Application (2016-2021) & (K Bottle)
Table 38. Global Recombinant Coagulation Factor Ⅷ for Injection Sales by Application (2022-2027) & (K Bottle)
Table 39. Global Recombinant Coagulation Factor Ⅷ for Injection Sales Share by Application (2016-2021)
Table 40. Global Recombinant Coagulation Factor Ⅷ for Injection Sales Share by Application (2022-2027)
Table 41. Global Recombinant Coagulation Factor Ⅷ for Injection Revenue by Application (2016-2021) & (US$ Million)
Table 42. Global Recombinant Coagulation Factor Ⅷ for Injection Revenue by Application (2022-2027) & (US$ Million)
Table 43. Global Recombinant Coagulation Factor Ⅷ for Injection Revenue Share by Application (2016-2021)
Table 44. Global Recombinant Coagulation Factor Ⅷ for Injection Revenue Share by Application (2022-2027)
Table 45. Recombinant Coagulation Factor Ⅷ for Injection Price by Application (2016-2021) & (US$/Bottle)
Table 46. Global Recombinant Coagulation Factor Ⅷ for Injection Price Forecast by Application (2022-2027) & (US$/Bottle)
Table 47. North America Recombinant Coagulation Factor Ⅷ for Injection Sales by Type (2016-2021) & (K Bottle)
Table 48. North America Recombinant Coagulation Factor Ⅷ for Injection Sales by Type (2022-2027) & (K Bottle)
Table 49. North America Recombinant Coagulation Factor Ⅷ for Injection Revenue by Type (2016-2021) & (US$ Million)
Table 50. North America Recombinant Coagulation Factor Ⅷ for Injection Revenue by Type (2022-2027) & (US$ Million)
Table 51. North America Recombinant Coagulation Factor Ⅷ for Injection Sales by Application (2016-2021) & (K Bottle)
Table 52. North America Recombinant Coagulation Factor Ⅷ for Injection Sales by Application (2022-2027) & (K Bottle)
Table 53. North America Recombinant Coagulation Factor Ⅷ for Injection Revenue by Application (2016-2021) & (US$ Million)
Table 54. North America Recombinant Coagulation Factor Ⅷ for Injection Revenue by Application (2022-2027) & (US$ Million)
Table 55. North America Recombinant Coagulation Factor Ⅷ for Injection Sales by Country (2016-2021) & (K Bottle)
Table 56. North America Recombinant Coagulation Factor Ⅷ for Injection Sales by Country (2022-2027) & (K Bottle)
Table 57. North America Recombinant Coagulation Factor Ⅷ for Injection Revenue by Country (2016-2021) & (US$ Million)
Table 58. North America Recombinant Coagulation Factor Ⅷ for Injection Revenue by Country (2022-2027) & (US$ Million)
Table 59. Europe Recombinant Coagulation Factor Ⅷ for Injection Sales by Type (2016-2021) & (K Bottle)
Table 60. Europe Recombinant Coagulation Factor Ⅷ for Injection Sales by Type (2022-2027) & (K Bottle)
Table 61. Europe Recombinant Coagulation Factor Ⅷ for Injection Revenue by Type (2016-2021) & (US$ Million)
Table 62. Europe Recombinant Coagulation Factor Ⅷ for Injection Revenue by Type (2022-2027) & (US$ Million)
Table 63. Europe Recombinant Coagulation Factor Ⅷ for Injection Sales by Application (2016-2021) & (K Bottle)
Table 64. Europe Recombinant Coagulation Factor Ⅷ for Injection Sales by Application (2022-2027) & (K Bottle)
Table 65. Europe Recombinant Coagulation Factor Ⅷ for Injection Revenue by Application (2016-2021) & (US$ Million)
Table 66. Europe Recombinant Coagulation Factor Ⅷ for Injection Revenue by Application (2022-2027) & (US$ Million)
Table 67. Europe Recombinant Coagulation Factor Ⅷ for Injection Sales by Country (2016-2021) & (K Bottle)
Table 68. Europe Recombinant Coagulation Factor Ⅷ for Injection Sales by Country (2022-2027) & (K Bottle)
Table 69. Europe Recombinant Coagulation Factor Ⅷ for Injection Revenue by Country (2016-2021) & (US$ Million)
Table 70. Europe Recombinant Coagulation Factor Ⅷ for Injection Revenue by Country (2022-2027) & (US$ Million)
Table 71. Asia Pacific Recombinant Coagulation Factor Ⅷ for Injection Sales by Type (2016-2021) & (K Bottle)
Table 72. Asia Pacific Recombinant Coagulation Factor Ⅷ for Injection Sales by Type (2022-2027) & (K Bottle)
Table 73. Asia Pacific Recombinant Coagulation Factor Ⅷ for Injection Revenue by Type (2016-2021) & (US$ Million)
Table 74. Asia Pacific Recombinant Coagulation Factor Ⅷ for Injection Revenue by Type (2022-2027) & (US$ Million)
Table 75. Asia Pacific Recombinant Coagulation Factor Ⅷ for Injection Sales by Application (2016-2021) & (K Bottle)
Table 76. Asia Pacific Recombinant Coagulation Factor Ⅷ for Injection Sales by Application (2022-2027) & (K Bottle)
Table 77. Asia Pacific Recombinant Coagulation Factor Ⅷ for Injection Revenue by Application (2016-2021) & (US$ Million)
Table 78. Asia Pacific Recombinant Coagulation Factor Ⅷ for Injection Revenue by Application (2022-2027) & (US$ Million)
Table 79. Asia Pacific Recombinant Coagulation Factor Ⅷ for Injection Sales by Region (2016-2021) & (K Bottle)
Table 80. Asia Pacific Recombinant Coagulation Factor Ⅷ for Injection Sales by Region (2022-2027) & (K Bottle)
Table 81. Asia Pacific Recombinant Coagulation Factor Ⅷ for Injection Revenue by Region (2016-2021) & (US$ Million)
Table 82. Asia Pacific Recombinant Coagulation Factor Ⅷ for Injection Revenue by Region (2022-2027) & (US$ Million)
Table 83. Latin America Recombinant Coagulation Factor Ⅷ for Injection Sales by Type (2016-2021) & (K Bottle)
Table 84. Latin America Recombinant Coagulation Factor Ⅷ for Injection Sales by Type (2022-2027) & (K Bottle)
Table 85. Latin America Recombinant Coagulation Factor Ⅷ for Injection Revenue by Type (2016-2021) & (US$ Million)
Table 86. Latin America Recombinant Coagulation Factor Ⅷ for Injection Revenue by Type (2022-2027) & (US$ Million)
Table 87. Latin America Recombinant Coagulation Factor Ⅷ for Injection Sales by Application (2016-2021) & (K Bottle)
Table 88. Latin America Recombinant Coagulation Factor Ⅷ for Injection Sales by Application (2022-2027) & (K Bottle)
Table 89. Latin America Recombinant Coagulation Factor Ⅷ for Injection Revenue by Application (2016-2021) & (US$ Million)
Table 90. Latin America Recombinant Coagulation Factor Ⅷ for Injection Revenue by Application (2022-2027) & (US$ Million)
Table 91. Latin America Recombinant Coagulation Factor Ⅷ for Injection Sales by Country (2016-2021) & (K Bottle)
Table 92. Latin America Recombinant Coagulation Factor Ⅷ for Injection Sales by Country (2022-2027) & (K Bottle)
Table 93. Latin America Recombinant Coagulation Factor Ⅷ for Injection Revenue by Country (2016-2021) & (US$ Million)
Table 94. Latin America Recombinant Coagulation Factor Ⅷ for Injection Revenue by Country (2022-2027) & (US$ Million)
Table 95. Middle East and Africa Recombinant Coagulation Factor Ⅷ for Injection Sales by Type (2016-2021) & (K Bottle)
Table 96. Middle East and Africa Recombinant Coagulation Factor Ⅷ for Injection Sales by Type (2022-2027) & (K Bottle)
Table 97. Middle East and Africa Recombinant Coagulation Factor Ⅷ for Injection Revenue by Type (2016-2021) & (US$ Million)
Table 98. Middle East and Africa Recombinant Coagulation Factor Ⅷ for Injection Revenue by Type (2022-2027) & (US$ Million)
Table 99. Middle East and Africa Recombinant Coagulation Factor Ⅷ for Injection Sales by Application (2016-2021) & (K Bottle)
Table 100. Middle East and Africa Recombinant Coagulation Factor Ⅷ for Injection Sales by Application (2022-2027) & (K Bottle)
Table 101. Middle East and Africa Recombinant Coagulation Factor Ⅷ for Injection Revenue by Application (2016-2021) & (US$ Million)
Table 102. Middle East and Africa Recombinant Coagulation Factor Ⅷ for Injection Revenue by Application (2022-2027) & (US$ Million)
Table 103. Middle East and Africa Recombinant Coagulation Factor Ⅷ for Injection Sales by Country (2016-2021) & (K Bottle)
Table 104. Middle East and Africa Recombinant Coagulation Factor Ⅷ for Injection Sales by Country (2022-2027) & (K Bottle)
Table 105. Middle East and Africa Recombinant Coagulation Factor Ⅷ for Injection Revenue by Country (2016-2021) & (US$ Million)
Table 106. Middle East and Africa Recombinant Coagulation Factor Ⅷ for Injection Revenue by Country (2022-2027) & (US$ Million)
Table 107. Pfizer Corporation Information
Table 108. Pfizer Description and Major Businesses
Table 109. Pfizer Recombinant Coagulation Factor Ⅷ for Injection Sales (K Bottle), Revenue (US$ Million), Price (US$/Bottle) and Gross Margin (2016-2021)
Table 110. Pfizer Recombinant Coagulation Factor Ⅷ for Injection Product Model Numbers, Pictures, Descriptions and Specifications
Table 111. Pfizer Recent Developments
Table 112. Novo Nordisk A/S Corporation Information
Table 113. Novo Nordisk A/S Description and Major Businesses
Table 114. Novo Nordisk A/S Recombinant Coagulation Factor Ⅷ for Injection Sales (K Bottle), Revenue (US$ Million), Price (US$/Bottle) and Gross Margin (2016-2021)
Table 115. Novo Nordisk A/S Recombinant Coagulation Factor Ⅷ for Injection Product Model Numbers, Pictures, Descriptions and Specifications
Table 116. Novo Nordisk A/S Recent Developments
Table 117. Baxter Corporation Information
Table 118. Baxter Description and Major Businesses
Table 119. Baxter Recombinant Coagulation Factor Ⅷ for Injection Sales (K Bottle), Revenue (US$ Million), Price (US$/Bottle) and Gross Margin (2016-2021)
Table 120. Baxter Recombinant Coagulation Factor Ⅷ for Injection Product Model Numbers, Pictures, Descriptions and Specifications
Table 121. Baxter Recent Developments
Table 122. Bayer Corporation Information
Table 123. Bayer Description and Major Businesses
Table 124. Bayer Recombinant Coagulation Factor Ⅷ for Injection Sales (K Bottle), Revenue (US$ Million), Price (US$/Bottle) and Gross Margin (2016-2021)
Table 125. Bayer Recombinant Coagulation Factor Ⅷ for Injection Product Model Numbers, Pictures, Descriptions and Specifications
Table 126. Bayer Recent Developments
Table 127. GC Pharma Corporation Information
Table 128. GC Pharma Description and Major Businesses
Table 129. GC Pharma Recombinant Coagulation Factor Ⅷ for Injection Sales (K Bottle), Revenue (US$ Million), Price (US$/Bottle) and Gross Margin (2016-2021)
Table 130. GC Pharma Recombinant Coagulation Factor Ⅷ for Injection Product Model Numbers, Pictures, Descriptions and Specifications
Table 131. GC Pharma Recent Developments
Table 132. Shanghai Raas Corp Corporation Information
Table 133. Shanghai Raas Corp Description and Major Businesses
Table 134. Shanghai Raas Corp Recombinant Coagulation Factor Ⅷ for Injection Sales (K Bottle), Revenue (US$ Million), Price (US$/Bottle) and Gross Margin (2016-2021)
Table 135. Shanghai Raas Corp Recombinant Coagulation Factor Ⅷ for Injection Product Model Numbers, Pictures, Descriptions and Specifications
Table 136. Shanghai Raas Corp Recent Developments
Table 137. Hualan Biological Corporation Information
Table 138. Hualan Biological Description and Major Businesses
Table 139. Hualan Biological Recombinant Coagulation Factor Ⅷ for Injection Sales (K Bottle), Revenue (US$ Million), Price (US$/Bottle) and Gross Margin (2016-2021)
Table 140. Hualan Biological Recombinant Coagulation Factor Ⅷ for Injection Product Model Numbers, Pictures, Descriptions and Specifications
Table 141. Hualan Biological Recent Developments
Table 142. Shandong Taibang Biological Products Corporation Information
Table 143. Shandong Taibang Biological Products Description and Major Businesses
Table 144. Shandong Taibang Biological Products Recombinant Coagulation Factor Ⅷ for Injection Sales (K Bottle), Revenue (US$ Million), Price (US$/Bottle) and Gross Margin (2016-2021)
Table 145. Shandong Taibang Biological Products Recombinant Coagulation Factor Ⅷ for Injection Product Model Numbers, Pictures, Descriptions and Specifications
Table 146. Shandong Taibang Biological Products Recent Developments
Table 147. Shanghai Xinxing Medicine Corporation Information
Table 148. Shanghai Xinxing Medicine Description and Major Businesses
Table 149. Shanghai Xinxing Medicine Recombinant Coagulation Factor Ⅷ for Injection Sales (K Bottle), Revenue (US$ Million), Price (US$/Bottle) and Gross Margin (2016-2021)
Table 150. Shanghai Xinxing Medicine Recombinant Coagulation Factor Ⅷ for Injection Product Model Numbers, Pictures, Descriptions and Specifications
Table 151. Shanghai Xinxing Medicine Recent Developments
Table 152. SinoCell Tech Corporation Information
Table 153. SinoCell Tech Description and Major Businesses
Table 154. SinoCell Tech Recombinant Coagulation Factor Ⅷ for Injection Sales (K Bottle), Revenue (US$ Million), Price (US$/Bottle) and Gross Margin (2016-2021)
Table 155. SinoCell Tech Recombinant Coagulation Factor Ⅷ for Injection Product Model Numbers, Pictures, Descriptions and Specifications
Table 156. SinoCell Tech Recent Developments
Table 157. Key Raw Materials Lists
Table 158. Raw Materials Key Suppliers Lists
Table 159. Recombinant Coagulation Factor Ⅷ for Injection Distributors List
Table 160. Recombinant Coagulation Factor Ⅷ for Injection Customers List
Table 161. Recombinant Coagulation Factor Ⅷ for Injection Market Trends
Table 162. Recombinant Coagulation Factor Ⅷ for Injection Market Drivers
Table 163. Recombinant Coagulation Factor Ⅷ for Injection Market Challenges
Table 164. Recombinant Coagulation Factor Ⅷ for Injection Market Restraints
Table 165. Research Programs/Design for This Report
Table 166. Key Data Information from Secondary Sources
Table 167. Key Data Information from Primary Sources
List of Figures
Figure 1. Recombinant Coagulation Factor Ⅷ for Injection Product Picture
Figure 3. Global Recombinant Coagulation Factor Ⅷ for Injection Market Share by Type in 2020 & 2027
Figure 3. 250 IU/Bottle Product Picture
Figure 4. 500 IU/Bottle Product Picture
Figure 5. 1000 IU/Bottle Product Picture
Figure 6. 2000 IU/Bottle Product Picture
Figure 7. Global Recombinant Coagulation Factor Ⅷ for Injection Market Share by Application in 2020 & 2027
Figure 8. Hospital
Figure 9. Clinic
Figure 10. Others
Figure 11. Recombinant Coagulation Factor Ⅷ for Injection Report Years Considered
Figure 12. Global Recombinant Coagulation Factor Ⅷ for Injection Sales 2016-2027 (K Bottle)
Figure 13. Global Recombinant Coagulation Factor Ⅷ for Injection Revenue, (US$ Million), 2016 VS 2021 VS 2027
Figure 14. Global Recombinant Coagulation Factor Ⅷ for Injection Revenue 2016-2027 (US$ Million)
Figure 15. Global Recombinant Coagulation Factor Ⅷ for Injection Revenue Market Share by Region in Percentage: 2020 Versus 2027
Figure 16. Global Recombinant Coagulation Factor Ⅷ for Injection Sales Market Share by Region (2016-2021)
Figure 17. Global Recombinant Coagulation Factor Ⅷ for Injection Sales Market Share by Region (2022-2027)
Figure 18. North America Recombinant Coagulation Factor Ⅷ for Injection Sales YoY (2016-2027) & (K Bottle)
Figure 19. North America Recombinant Coagulation Factor Ⅷ for Injection Revenue YoY (2016-2027) & (US$ Million)
Figure 20. Europe Recombinant Coagulation Factor Ⅷ for Injection Sales YoY (2016-2027) & (K Bottle)
Figure 21. Europe Recombinant Coagulation Factor Ⅷ for Injection Revenue YoY (2016-2027) & (US$ Million)
Figure 22. Asia-Pacific Recombinant Coagulation Factor Ⅷ for Injection Sales YoY (2016-2027) & (K Bottle)
Figure 23. Asia-Pacific Recombinant Coagulation Factor Ⅷ for Injection Revenue YoY (2016-2027) & (US$ Million)
Figure 24. Latin America Recombinant Coagulation Factor Ⅷ for Injection Sales YoY (2016-2027) & (K Bottle)
Figure 25. Latin America Recombinant Coagulation Factor Ⅷ for Injection Revenue YoY (2016-2027) & (US$ Million)
Figure 26. Middle East & Africa Recombinant Coagulation Factor Ⅷ for Injection Sales YoY (2016-2027) & (K Bottle)
Figure 27. Middle East & Africa Recombinant Coagulation Factor Ⅷ for Injection Revenue YoY (2016-2027) & (US$ Million)
Figure 28. The Top 10 and Top 5 Players Market Share by Recombinant Coagulation Factor Ⅷ for Injection Sales in 2020
Figure 29. The Top 10 and Top 5 Players Market Share by Recombinant Coagulation Factor Ⅷ for Injection Revenue in 2020
Figure 30. Recombinant Coagulation Factor Ⅷ for Injection Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2016 VS 2020
Figure 31. Global Recombinant Coagulation Factor Ⅷ for Injection Sales Market Share by Type (2016-2027)
Figure 32. Global Recombinant Coagulation Factor Ⅷ for Injection Revenue Market Share by Type (2016-2027)
Figure 33. Global Recombinant Coagulation Factor Ⅷ for Injection Sales Market Share by Application (2016-2027)
Figure 34. Global Recombinant Coagulation Factor Ⅷ for Injection Revenue Market Share by Application (2016-2027)
Figure 35. North America Recombinant Coagulation Factor Ⅷ for Injection Sales Market Share by Type (2016-2027)
Figure 36. North America Recombinant Coagulation Factor Ⅷ for Injection Revenue Market Share by Type (2016-2027)
Figure 37. North America Recombinant Coagulation Factor Ⅷ for Injection Sales Market Share by Application (2016-2027)
Figure 38. North America Recombinant Coagulation Factor Ⅷ for Injection Revenue Market Share by Application (2016-2027)
Figure 39. North America Recombinant Coagulation Factor Ⅷ for Injection Sales Share by Country (2016-2027)
Figure 40. North America Recombinant Coagulation Factor Ⅷ for Injection Revenue Share by Country (2016-2027)
Figure 41. United States Recombinant Coagulation Factor Ⅷ for Injection Revenue (2016-2027) & (US$ Million)
Figure 42. Canada Recombinant Coagulation Factor Ⅷ for Injection Revenue (2016-2027) & (US$ Million)
Figure 43. Europe Recombinant Coagulation Factor Ⅷ for Injection Sales Market Share by Type (2016-2027)
Figure 44. Europe Recombinant Coagulation Factor Ⅷ for Injection Revenue Market Share by Type (2016-2027)
Figure 45. Europe Recombinant Coagulation Factor Ⅷ for Injection Sales Market Share by Application (2016-2027)
Figure 46. Europe Recombinant Coagulation Factor Ⅷ for Injection Revenue Market Share by Application (2016-2027)
Figure 47. Europe Recombinant Coagulation Factor Ⅷ for Injection Sales Share by Country (2016-2027)
Figure 48. Europe Recombinant Coagulation Factor Ⅷ for Injection Revenue Share by Country (2016-2027)
Figure 49. Germany Recombinant Coagulation Factor Ⅷ for Injection Revenue (2016-2027) & (US$ Million)
Figure 50. France Recombinant Coagulation Factor Ⅷ for Injection Revenue (2016-2027) & (US$ Million)
Figure 51. U.K. Recombinant Coagulation Factor Ⅷ for Injection Revenue (2016-2027) & (US$ Million)
Figure 52. Italy Recombinant Coagulation Factor Ⅷ for Injection Revenue (2016-2027) & (US$ Million)
Figure 53. Russia Recombinant Coagulation Factor Ⅷ for Injection Revenue (2016-2027) & (US$ Million)
Figure 54. Asia Pacific Recombinant Coagulation Factor Ⅷ for Injection Sales Market Share by Type (2016-2027)
Figure 55. Asia Pacific Recombinant Coagulation Factor Ⅷ for Injection Revenue Market Share by Type (2016-2027)
Figure 56. Asia Pacific Recombinant Coagulation Factor Ⅷ for Injection Sales Market Share by Application (2016-2027)
Figure 57. Asia Pacific Recombinant Coagulation Factor Ⅷ for Injection Revenue Market Share by Application (2016-2027)
Figure 58. Asia Pacific Recombinant Coagulation Factor Ⅷ for Injection Sales Share by Region (2016-2027)
Figure 59. Asia Pacific Recombinant Coagulation Factor Ⅷ for Injection Revenue Share by Region (2016-2027)
Figure 60. China Recombinant Coagulation Factor Ⅷ for Injection Revenue (2016-2027) & (US$ Million)
Figure 61. Japan Recombinant Coagulation Factor Ⅷ for Injection Revenue (2016-2027) & (US$ Million)
Figure 62. South Korea Recombinant Coagulation Factor Ⅷ for Injection Revenue (2016-2027) & (US$ Million)
Figure 63. India Recombinant Coagulation Factor Ⅷ for Injection Revenue (2016-2027) & (US$ Million)
Figure 64. Australia Recombinant Coagulation Factor Ⅷ for Injection Revenue (2016-2027) & (US$ Million)
Figure 65. China Taiwan Recombinant Coagulation Factor Ⅷ for Injection Revenue (2016-2027) & (US$ Million)
Figure 66. Indonesia Recombinant Coagulation Factor Ⅷ for Injection Revenue (2016-2027) & (US$ Million)
Figure 67. Thailand Recombinant Coagulation Factor Ⅷ for Injection Revenue (2016-2027) & (US$ Million)
Figure 68. Malaysia Recombinant Coagulation Factor Ⅷ for Injection Revenue (2016-2027) & (US$ Million)
Figure 69. Latin America Recombinant Coagulation Factor Ⅷ for Injection Sales Market Share by Type (2016-2027)
Figure 70. Latin America Recombinant Coagulation Factor Ⅷ for Injection Revenue Market Share by Type (2016-2027)
Figure 71. Latin America Recombinant Coagulation Factor Ⅷ for Injection Sales Market Share by Application (2016-2027)
Figure 72. Latin America Recombinant Coagulation Factor Ⅷ for Injection Revenue Market Share by Application (2016-2027)
Figure 73. Latin America Recombinant Coagulation Factor Ⅷ for Injection Sales Share by Country (2016-2027)
Figure 74. Latin America Recombinant Coagulation Factor Ⅷ for Injection Revenue Share by Country (2016-2027)
Figure 75. Mexico Recombinant Coagulation Factor Ⅷ for Injection Revenue (2016-2027) & (US$ Million)
Figure 76. Brazil Recombinant Coagulation Factor Ⅷ for Injection Revenue (2016-2027) & (US$ Million)
Figure 77. Argentina Recombinant Coagulation Factor Ⅷ for Injection Revenue (2016-2027) & (US$ Million)
Figure 78. Colombia Recombinant Coagulation Factor Ⅷ for Injection Revenue (2016-2027) & (US$ Million)
Figure 79. Middle East and Africa Recombinant Coagulation Factor Ⅷ for Injection Sales Market Share by Type (2016-2027)
Figure 80. Middle East and Africa Recombinant Coagulation Factor Ⅷ for Injection Revenue Market Share by Type (2016-2027)
Figure 81. Middle East and Africa Recombinant Coagulation Factor Ⅷ for Injection Sales Market Share by Application (2016-2027)
Figure 82. Middle East and Africa Recombinant Coagulation Factor Ⅷ for Injection Revenue Market Share by Application (2016-2027)
Figure 83. Middle East and Africa Recombinant Coagulation Factor Ⅷ for Injection Sales Share by Country (2016-2027)
Figure 84. Middle East and Africa Recombinant Coagulation Factor Ⅷ for Injection Revenue Share by Country (2016-2027)
Figure 85. Turkey Recombinant Coagulation Factor Ⅷ for Injection Revenue (2016-2027) & (US$ Million)
Figure 86. Saudi Arabia Recombinant Coagulation Factor Ⅷ for Injection Revenue (2016-2027) & (US$ Million)
Figure 87. UAE Recombinant Coagulation Factor Ⅷ for Injection Revenue (2016-2027) & (US$ Million)
Figure 88. Recombinant Coagulation Factor Ⅷ for Injection Value Chain
Figure 89. Recombinant Coagulation Factor Ⅷ for Injection Production Process
Figure 90. Channels of Distribution
Figure 91. Distributors Profiles
Figure 92. Bottom-up and Top-down Approaches for This Report
Figure 93. Data Triangulation
Figure 94. Key Executives Interviewed

---